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This review will first focus on the regulation of TG lipolysis and how the understanding of TG regulation has evolved since the discovery and partial characterization of adipose triglyceride lipase (ATGL) only 5 years ago. The review will then outline how changes in TG metabolism can influence adipocyte and skeletal muscle metabolism and summarize the recent evidence suggesting that altering flux through the TG pool may mediate local changes in mitochondrial capacity and an enhanced capacity to dispose of "excess" fatty acids through oxidative pathways.
Triacylglycerol Lipases Act in Series to Regulate Lipolysis
The sequential hydrolysis of TG by specific enzymes results in the liberation of a fatty acid (FA) at each step with the generation of diacylglycerol (DG), monoacylglycerol (MG), and glycerol. For many years hormone-sensitive lipase (HSL) was presumed to be the rate-limiting enzyme controlling this process. Studies over the past two decades have demonstrated the important role of phosphorylation by stress-activated protein kinases in controlling HSL intracellular localization, enzyme activity, and interaction with accessory proteins, such as perilipin A, to ultimately control lipolysis (83) . However, HSL-null mice accumulated DG and were able to maintain basal and some degree of ␤-adrenergic stimulated lipolysis, suggesting the requirement of alternative enzymes for TG hydrolysis (32, 58, 75) . In 2004, three laboratories identified these enzymes as desnutrin, phospholipase A2-, and ATGL (39, 74, 84) . ATGL exhibits high substrate specificity for TG (84) , and its activity is increased markedly by association with comparative gene identification-58 (CGI-58) (51). Combined with the knowledge that HSL exhibits markedly greater activity against DG vs. TG substrate (23) , these findings have led to the current view that ATGL and HSL work hierarchically to regulate complete TG hydrolysis. ATGL initiates lipolysis by specifically removing the first FA from TG to produce DG substrate, which is then hydrolyzed by HSL to generate an additional FA and MG substrate. MGs are converted to FA and glycerol by MG lipase in the final step of lipolysis (23) .
Because MGs do not accumulate in adipocytes, even under conditions of maximally activated lipolysis, MG lipase is not considered to be rate limiting for lipolysis and will not be discussed herein. Due to differences in the tissue-specific expression of ATGL and HSL, there may also be a role for other members of the recently identified lipolytic proteome (6) .
Regulation of TG Lipases
ATGL. ATGL is expressed in most tissues examined, with the highest expression in white and brown adipose tissue, lower levels in the testis and cardiac and skeletal muscle, and very low expression in the liver (32, 42, 48, 58, 74, 75, 84) . Unless stated otherwise, the following sections discuss ATGL in the adipocyte. ATGL exhibits high substrate specificity for TG, very weak activity against DG, and no activity against cholesterol or retinyl ester bonds (84) . It is now unequivocal that ATGL mediates basal and ␤-adrenergic TG lipolysis in adipocytes (1, 5, 42, 49, 84) and other cell types, including skeletal muscle (80) , hepatocytes (61) , embryonic kidney (48) , and cancer cells (69) . These cell-based studies are supported by interventions in several lower-order species (e.g., S. cerevisiae, Drosophila) (30, 47) and mice (1, 31) , showing that ATGL deletion induces obesity and that ATGL overexpression confers a lean phenotype. Similarly, in vivo ATGL overexpression in skeletal muscle (80) or liver (61) reduced TG mass. Finally, immunoinhibition of ATGL in human adipose tissue lysates reduced total TG lipase activity by 70 -83%, indicating an important role for ATGL in human adipocyte lipolysis (71) . Aside from its role in TG degradation, Jenkins et al. (39) reported acylglycerol transacylase activity of ATGL using an oleate donor, which in the presence of monoolein or diolein produced DG and TG, respectively. This unusual finding is relevant for TG futile cycling, which is proposed to provide a continuous pool of FAs to facilitate an immediate response to the metabolic demands of organisms (56) . The implications of this are discussed later.
The molecular regulation of ATGL is slowly being elucidated. ATGL transcription is subject to nutritional/hormonal regulation. ATGL expression is induced during adipogenesis and, consistent with this notion, is upregulated by peroxisome proliferator-activated receptor (PPAR)␥ (43, 44) . Tumor necrosis factor (TNF)␣ suppressed ATGL expression (44, 46) , which mirrored the TNF␣ downregulation of PPAR␥, and insulin also suppressed ATGL expression (42, 44, 46) by restraining the nuclear localization of forkhead box O1 (10) . There are conflicting reports on ATGL regulation by ␤-adrenergic agonists (46, 74) .
In adipocytes, the posttranslational regulation of ATGL appears to involve translocation, protein-protein interactions, and possibly phosphorylation. The predicted NH 2 -terminal active sites within the ␣/␤ hydrolase fold, S47 and D166, are critical for ATGL-mediated TG hydrolysis ( Fig. 1) (20, 48) . Biochemical evaluation of cell lysates and high-resolution imaging of fluorescence reporters in living cells also show that ATGL resides in the cytoplasm and on lipid droplets (LD) in the basal state (28, 84) , and cAMP-dependent protein kinase (PKA) activation elicits only minor translocation of ATGL to LDs (28) . The COOH-terminal region of ATGL that contains a hydrophobic region is essential for this appropriate cellular localization and association with LDs (45, 65) , whereas the NH 2 -terminal region (residues 10 -24) appears to be important for TG binding (20) . ATGL activity does not appear to be regulated directly by PKA phosphorylation, although preliminary evidence in mammalian cells indicates that ATGL is phosphorylated by other unknown kinases (84) . A phosphoprotein proteomic analysis of purified LDs reported phosphorylation at Ser 404 and Ser 428 of human ATGL (4); however, site-directed mutagenesis of these sites did not affect TG breakdown under basal conditions (20) . Hence, the reason for ATGL phosphorylation in cells is currently unresolved, as are the upstream kinases. Interestingly, AMP-activated protein kinase (AMPK) phosphorylation of ATGL (Ser 303 ) in C. elegans is required to suppress the rapid depletion of lipid stores during dauer (fasting) (54); however, the relevance to mammals is uncertain because of the low-sequence homology with C. elegans.
A major advance in understanding lipolysis was the discovery that ATGL requires CGI-58 for full activation. Lass et al. (51) demonstrated that CGI-58 interaction with ATGL increased adipose tissue TG hydrolase activity 20-fold, although others have since reported less dramatic increases (30 -70%) in cultured nonadipose cells (9, 80, 82) , possibly reflecting the low abundance of ATGL in these cells. Perilipin A is also implicated in ATGL activation. Perilipin A serves a critical role in regulating basal and stimulated lipolysis by coordinating the recruitment of proteins to the lipid droplet (7) . CGI-58 resides on the surface of lipid droplets and interacts with perilipin A under basal conditions, and after ␤-adrenergic stimulation, CGI-58 rapidly disperses into the cytoplasm (8, 28, 82) . Phosphorylation at Ser 517 of perilipin A is mandatory for stimulated lipolysis (53) and may mediate the dissociation of perilipin A and CGI-58. It appears that, after dissociation from perilipin A, CGI-58 associates with ATGL predominantly at micro (fragmented) lipid droplets and sites lacking perilipin A (28, 82) . Such regulation is unlikely to occur in other cell types that do not express perilipin A, and potential regulation by other members of the perilipin family, including PLIN2 (adipocyte differentiation-related protein), PLIN3 (tail-interacting protein of 47 kDa), PLIN4 (S3-12), and PLIN5 (LSDP5), requires more study. Finally, recent work shows that the adipokine pigment epithelium-derived factor, which is elevated in obesity (15), associates with ATGL (13) and enhances adipocyte lipolysis (15) .
HSL. Since the discovery of ATGL, HSL has taken the "back seat" with respect to research focus of lipolytic regulation. HSL remains a critical enzyme for complete TG lipolysis, and its characterization and function have been extensively reviewed elsewhere (35, 78, 83) . HSL is expressed in adipocytes and less so in many other tissues, including skeletal muscle, pancreas, macrophages, and testis (34) . HSL exerts lipolytic activity toward not only TG but also DG, MG, and cholesteryl esters. The relative hydrolase activity in vitro is 11-fold greater against DG than TG (23), and this substrate preference was supported by studies in HSL-null mice that reported marked DG accumulation (32) . HSL contains three domains: a catalytic domain, a regulatory domain containing several phosphorylation sites, and an NH 2 -terminal domain involved in protein-protein and protein-lipid interactions (Fig. 1) . Although it was known for several years that PKA increased HSL activity through a phosphorylation-dependent mechanism, mutagenesis experiments demonstrated dependence for this effect on phosphorylation at Ser 563 , Ser 659 , and Ser 660 (2, 67) . However, it should be noted that there is some doubt as to the importance of Ser 563 (2) . The PKA phosphorylation of HSL results in modest activation of the enzyme (2-to 3-fold) and promotes the translocation of HSL to the LD (21) , an effect that is critical for enhancing lipolytic capacity as a result of ␤-adrenergic stimulation. The extracellular signalregulated kinase phosphorylates HSL at Ser 600 , which increases HSL activity (29) . HSL activity is negatively regulated by insulin (22, 55) and via phosphorylation of HSL Ser 565 by AMPK (18, 26) . LDs are bound by a family of proteins that contain PAT domains (for perilipin, adipose differentiationrelated protein, and tail-interacting protein 47 kDa). Perilipin A appears to be the most critical for regulating HSL activity in adipocytes, whereas other PAT proteins are likely to be important for lipolytic regulation in most other tissues that do not express perilipin A. Readers are directed to an excellent recent review of this topic (7). PKA phosphorylation of perilipin A is critical for HSL lipolytic action at the LD (53), which is mediated by direct binding, although the exact residues have not been determined (28, 66) . This regulation is not relevant for other key tissues of FA metabolism that do not express perilipin A.
ATGL and Mitochondrial Biogenesis
Aside from their role in energy metabolism, FAs are involved in a myriad of cellular process, one of which is serving as PPAR ligands. PPARs belong to the nuclear hormone receptor superfamily that functions as FA-activated transcription factors. The PPAR family consists of several isoforms that display tissue specificity and discrete physiological functions. PPAR␣ is expressed predominantly in liver and controls mitochondrial and peroxisomal FA catabolism, whereas PPAR␥ is abundant in adipose tissue and is a key transcription factor for adipogenesis. Although PPAR␥ is lowly expressed in skeletal muscle, it nevertheless exerts an important role in metabolism in this tissue (33) . PPAR␦ is highly expressed in skeletal muscle, and its activation induces the expression of genes involved in ␤-oxidation, energy uncoupling, and cholesterol efflux (19) . Indeed, treating mice with PPAR␦ ligands (GW1516) can reprogram the muscle transcriptome and is sufficient to initiate an oxidative response in skeletal muscle in vivo (55) .
ATGL is a TG hydrolase in skeletal muscle that alters fat metabolism. Retroviral-mediated ATGL overexpression in muscle cells increases TG lipase activity (80) (85) and macrophages (11) . Furthermore, ATGL overexpression enhances lipolysis and drives PPAR␣ activity in rat hepatocytes (64) , and ATGL overexpression in adipocytes increases the expression of PPAR target genes (1). Also, PPAR␥ agonism increases adipose tissue lipolysis, mitochondrial biogenesis, and FA oxidation (50, 81) . Together, these data support a presumptive role for ATGL-mediated TG hydrolysis in providing ligand for PPAR␣/␦/␥ activation, which in turn would drive transcription of FA catabolism genes and enhanced fat-burning capacity in several cell types (Fig. 2) . In other words, whenever ATGL is activated to release FAs for oxidation, such as during fasting or moderate physical activity, the FAs serve a dual or supplementary role as signals to activate the expression of genes that may be required should the requirement for increased fat fuel persist (e.g., exercise training, high-fat feeding). Of course, the relevant question in humans is, what type of repetitive "real-world" signal would be needed to cause the translation of this putative regulatory network in vivo?
AMPK may also play a role in the regulation of adipocyte mitochondrial biogenesis. Lipolysis decreases the cellular energy state, presumably due to the ATP hydrolysis required for acylation of the released FAs (27) , and lipolysis thereby activates AMPK (27) . Futile cycling of FAs is also an energyconsuming process. The reesterification of free FAs (FFA) requires acylation by acyl-CoA synthetase (2ϫ ATP), whereas the putative and actual phosphorylation of lipolytic (ATGL, HSL) and esterification (glycerol-3-phosphate acyltransferase, diacylglycerol acyltransferase; Ref. 53 and Watt MJ, unpublished observations) enzymes would also contribute to ATP use, leading to increased free AMP. Additional studies have also demonstrated that increasing FA availability enhances AMPK activity (79) . Hence, activation of ATGL, which possesses both TG lipase and possibly acylglycerol transacylase activity (39) , places this enzyme at the crossroads of futile cycle control in adipocytes. Irrespective of the activating pathways, studies employing chemical activators or exercise show that AMPK promotes mitochondrial biogenesis (37, 40, 86) . Although the underlying mechanism(s) remains unresolved, PGC-1␣ coactivates several transcription factors involved in mitochondrial biogenesis, and its expression and activity are regulated by AMPK (37) . Further studies are necessary to clarify these relationships.
TG Lipases, FA Flux, and Tissue-Specific Substrate Metabolism
Skeletal muscle. Intramuscular triacylglycerols (IMTGs) are stored within LDs located in the cytoplasm of skeletal muscle cells and in close proximity to the mitochondria (8) , where the TG-derived FAs are released for oxidation. The energy stored within the IMTG pool is usually equivalent to that stored in muscle glycogen, and although the contribution of IMTG-derived FAs for energy provision has historically been difficult to assess, several experimental approaches show that IMTGs provide an important contribution toward energy utilization at rest and during physical activity (76) . Several recent developments now suggest that IMTGs, and by association TG lipases, may be more important in metabolic control than originally thought.
A long-held belief is that plasma-derived FFAs are the most important source of FA for ATP production in skeletal muscle. In support of this notion, FFA tracer studies have reported leg release of isotopically labeled CO 2 that was temporally consistent with the direct entry of FFAs into a long-chain acylCoA pool for immediate mitochondrial oxidation (60, 63) . However, Dagenais et al. (17) provided the first evidence that plasma-derived FAs may enter the IMTG pool before their eventual oxidation. Kanaley et al. (41) recently combined a "pulse-chase" study design using 13 C-FFA tracers in humans with sensitive mass spectrometry determination of muscle lipids and showed that the direct contribution of plasma FFAs to muscle FA oxidation under resting conditions is negligible. Instead, the isotopic enrichments are consistent with the interpretation that FFAs must first be diluted into intracellular pools (presumably IMTG). ATGL Ϫ/Ϫ mice (31) and mice with mutant perilipin that cannot be phosphorylated by PKA (Peri AKO⌬1-6) (70) have defective brown adipose tissue lipolysis, FA oxidation, and thermogenesis, demonstrating that this cycling of FAs occurs in other cell types. These findings suggest that TG lipases are critical in modulating whole body FA metabolism and would place ATGL/HSL at the forefront of potential therapeutic interventions aimed at enhancing FA oxidation, which has been proposed as a therapy for obesityassociated insulin resistance/type 2 diabetes (68).
Indeed, ATGL Ϫ/Ϫ and HSL Ϫ/Ϫ mice have impaired TG lipolysis and FA metabolism (36) , which supports the model proposed by Dagenais et al. (17) and Kanaley et al. (41) ; however, these transgenic models are confounded by reduced plasma FA levels. Also, mild short-term ATGL overexpression in skeletal muscle does not enhance insulin action in vivo (80) . Future studies using muscle-specific ablation of TG lipases will be important tools to address this issue and also extend this work to the exercise situation.
Adipocytes. An emerging model that is formulated from the metabolic characterization of several genetic mouse models suggests that elevating adipocyte lipolysis promotes FA oxidation and increased energy expenditure, albeit not necessarily through common mechanisms, resulting in a leaner phenotype. For example, adipose-specific ATGL transgenic mice have increased lipolysis, enhanced oxygen consumption, and increased adipocyte FA oxidation that was ascribed to a transcriptional reprogramming of the adipose tissue toward a more "oxidative" phenotype (1). Similar, albeit not completely overlapping, phenotypes have been reported in perilipin-null (52), fat-specific protein of 27-kDa-null (57), and adipocyte phospholipase-A2-null (38) mice. The described changes were restricted mostly to the adipocyte, which is consistent with the notion that enhancing intracellular FFA flux is driving gene transcription (described above). Considering that mitochondrial content and oxygen consumption are reduced in the adipose tissue of genetic and fat-induced obesity (12, 62, 73, 81) and that enhancing adipocyte mitochondrial function promotes leanness (14, 16, 59) , enhancing lipolytic flux in adipocytes by regulating TG lipase activity may be a viable approach to prevent obesity or ameliorate existing obesity. "Shifting" white adipose tissue toward a brown adipose phenotype that is characterized by mitochondrial biogenesis and uncoupled respiration is not a novel strategy for obesity treatment (72) . The advantage of upregulating TG lipases is that both lipolysis and respiration are concomitantly enhanced. Such an approach would only be advantageous if the FA from TG hydrolysis were oxidized locally, rather than released, which would obviate the requirement to dispose of "excess" FAs in nonadipose tissues and circumvent the potential for lipotoxicity.
Conclusions
Researchers have known for more than a century that FAs are an important metabolic substrate (3) and presumed for about 25 years that HSL was the critical enzyme controlling FA availability (24) . The discovery of ATGL has altered the view of lipolytic control and reignited the field of TG metabolism, with several studies revealing novel roles for TG lipases in metabolic control. We now know that ATGL is an essential protein in the lipolytic cascade and in the regulation of body mass. However, there is also much to be examined. How is ATGL regulated in adipocytes and other cell types? Where is ATGL placed in the regulation of intracellular fatty acid oxidation and metabolic control? Can regulating ATGL and FA fluxes influence the capacity of cells to respond to energy stresses by enhancing mitochondrial function? And how can ATGL be targeted for therapeutic benefit for the treatment of obesity and related disorders? Future research will answer these questions and further elucidate the important role for ATGL in cellular function, metabolic homeostasis, and disease prevention. 
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